Another report reveals Hsa_circ_0025202 competitively binds to miR-182-5p, relieves its inhibitory effect on FOXO3a expression, thereby inhibiting tumor progression and restoring the sensitivity of breast cancer cells to TAM (Sang et al., 2019). Here, FOXO3 is linked to breast carcinoma.